Page 53 - நரம்பியல் மருத்துவ ஆராய்ச்சி நிறுவனம் இல் மாசசூசெட்ஸ் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from நரம்பியல் மருத்துவ ஆராய்ச்சி நிறுவனம் இல் மாசசூசெட்ஸ். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In நரம்பியல் மருத்துவ ஆராய்ச்சி நிறுவனம் இல் மாசசூசெட்ஸ் Today - Breaking & Trending Today

Neuralink: Elon Musk's company that wants to put microchips in people's brains

It s developing neural interface technology a.k.a. putting microchips into people s brains.
The technology could help study and treat neurological disorders.
Tesla billionaire Elon Musk is known for high-profile companies like Tesla and SpaceX, but the billionaire also has a handful of unusual ventures. One them, he says, he started to one day achieve symbiosis between the human brain and artificial intelligence.
Neuralink is Musk s neural interface technology company. Simply put, it is building technology that could be embedded in a person s brain, where it could both record brain activity and potentially stimulate it.
While Musk likes to talk up his futuristic vision for the technology, merging human consciousness with AI, the tech has plenty of near-term potential medical applications such as the treatment of Parkinson s disease. ....

Andrew Jackson , Elon Musk , Max Hoda , Lex Fridman , Newcastle University , University Of Utah , University Of Newcastle , Andrew Hires , Professor Andrew Jackson , Jason Shepherd , Weekend Bi Uk , Isobel Asher Hamilton , ஆண்ட்ரூ ஜாக்சன் , அதிகபட்சம் ஹோடா , லெக்ஸ் ஃப்ரிட்மேன் , நியூகேஸில் பல்கலைக்கழகம் , பல்கலைக்கழகம் ஆஃப் உட்டா , பல்கலைக்கழகம் ஆஃப் நியூகேஸில் , ஆண்ட்ரூ பணியமர்த்தல் , ப்ரொஃபெஸர் ஆண்ட்ரூ ஜாக்சன் , ஜேசன் மேய்ப்பன் , வார இறுதி இரு இங்கிலாந்து , ஐசோபல் ஆஷர் ஹாமில்டன் ,

$100 million for major advances in medical research technology

The Morrison Government is investing $100 million into the development of new technologies to improve diagnosis and treatment of stroke, epilepsy and. ....

Andreas Fouras , Geoffrey Donnan , Stephen Davis , Graeme Jackson , Stage Two Of The Frontier Health , University Of Melbourne , Australian Lung Health Initiative , Mental Health , Research Initiative , University Of Melbourne Australian Stroke Alliance , Florey Institute Of Neuroscience , Morrison Government , Florey Institute , Stage Two , Frontier Health , Medical Research Initiative , Stroke Golden Hour , Australian Epilepsy Project , Functional Diagnosis , Professor Stephen , Australian Stroke , Department Of Health , Health Care , Artificial Intelligence , Medical Research , Lung Disease ,

Consultation on discussion paper on Global Action Plan on Epilepsy and Other Neurological Disorders

Neurological disorders are the leading cause of disability-adjusted-life-years and the second leading cause of death globally. Despite the global burden. ....

World Health Assembly , United Nations , Seventy Third World Health Assembly , United Nation , Member States , Seventy Fifth World Health Assembly , World Health Organization , Health Care , உலகம் ஆரோக்கியம் சட்டசபை , ஒன்றுபட்டது நாடுகள் , எழுபது மூன்றாவது உலகம் ஆரோக்கியம் சட்டசபை , ஒன்றுபட்டது தேசம் , உறுப்பினர் மாநிலங்களில் , எழுபது ஐந்தாவது உலகம் ஆரோக்கியம் சட்டசபை , உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந் , ஆரோக்கியம் பராமரிப்பு , கால் கை வலிப்பு ,

Two new genes linked to Alzheimer's disease discovered

E-Mail
IMAGE: A schematic overview of the study design. AD = Alzheimer s disease; ADNI = Alzheimer s disease Neuroimaging Initiative; ADSP = Alzheimer s disease Sequencing Project; cis-GReX = cis-genetically regulated expression; FOCUS =.
view more
Credit: Liu N, et al., 2021, PLOS Genetics
A research team led by Chunshui Yu and Mulin Jun Li of Tianjin Medical University has discovered two new genes potentially involved in Alzheimer s disease. They identified them by exploring which genes were turned on and off in the hippocampus of people who suffered from the disease. The team s new findings are published February 25th in
PLOS Genetics.
Alzheimer s disease is a neurodegenerative disorder that involves worsening dementia and the formation of protein plaques and tangles in the brain. The hippocampus, part of the brain involved in memory, is one of the first regions to sustain damage. To better understand which genes contribute to the progres ....

Mulin Jun Li , Chunshui Yu , National Natural Science Foundation Of China , National Key Research , Tianjin Key Technology Rd Program , Tianjin Medical University , Development Program Of China , Development Program , National Natural Science Foundation , Medicine Health , Alzheimers Disease , தேசிய இயற்கை அறிவியல் அடித்தளம் ஆஃப் சீனா , தேசிய விசை ஆராய்ச்சி , வளர்ச்சி ப்ரோக்ர்யாம் ஆஃப் சீனா , வளர்ச்சி ப்ரோக்ர்யாம் , தேசிய இயற்கை அறிவியல் அடித்தளம் , மருந்து ஆரோக்கியம் , அல்சைமர் நோய் ,

Researchers probe deeper into the neuronal mechanisms underlying olfactory dysfunction in Alzheimer's

Researchers probe deeper into the neuronal mechanisms underlying olfactory dysfunction in Alzheimer’s
Loss of smell or olfactory dysfunction is an early indication of the neurodegenerative Alzheimer s disease (AD) and appears in approximately 90% of all patients. While loss of smell is a major symptom, patients with AD are only unable to recognize specific odors and do not completely lose their sense of smell; this suggests a possible region-specific involvement of the olfactive center in the brain.
Amyloid β (Aβ), a toxic protein that accumulates in the brain is a known contributing factor in AD pathogenesis and is also present in the olfactory system that controls the sense of smell. However, the pathology and mechanisms of AD-specific olfactory dysfunction involving olfactory sensory neurons (OSNs) remain unclear. ....

Emily Henderson , Alzheimer Research , Professor Cheil Moon , Alzheimer 39s Disease , Mouse Model , எமிலி ஹென்டர்சன் , முதுமறதி ஆராய்ச்சி , சுட்டி மாதிரி ,